valproic acid has been researched along with sumatriptan in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (32.43) | 18.2507 |
| 2000's | 11 (29.73) | 29.6817 |
| 2010's | 11 (29.73) | 24.3611 |
| 2020's | 3 (8.11) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Solomon, GD | 1 |
| Welch, KM | 1 |
| Raskin, NH | 1 |
| Caffarri, G; Capretti, L; Chiodera, P; Cigarini, C; Coiro, V; Gramellini, D; Necchi Ghiri, S; Volpi, R | 1 |
| Kaplan, B; Swain, RA | 1 |
| Zurlinden, J | 2 |
| Suzuki, N | 1 |
| Dormehl, IC; Oliver, DW | 1 |
| Loewen, PS; Robinson, G; Zed, PJ | 1 |
| Bolden-Watson, CP; Davis, RL; Fox, AW; Gutterman, DL; O'Quinn, S; Putnam, GP | 1 |
| Ferrari, MD; Frants, RR; Ophoff, RA; Roon, KI; van den Maagdenberg, AM | 1 |
| Zakrzewska, JM | 1 |
| Evers, S; Gerber, WD; Naumann, E; Pothmann, R; Uberall, M | 1 |
| Bjerve, KS; Hagen, K; Stovner, LJ; Waage, A | 1 |
| Chmiel, JJ; Silberstein, SD; Winner, PK | 1 |
| Nakazato, Y; Shimazu, K; Tamura, N | 1 |
| Jensen, RH; Tfelt-Hansen, PC | 1 |
| Bakhshayesh, B; Hatamian, H; Hossieninezhad, M; Rezania, K; Seyed Saadat, SM | 1 |
| Owada, K | 1 |
| Ghaderibarmi, F; Tavakkoli, N; Togha, M | 1 |
| Charles, A; McGuire, B; Pradhan, AA; Tarash, I; Tipton, AF | 1 |
| Abu Bakar, MA; Baharuddin, KA; Norhayati, MN; Nurathirah, MN; Yazid, MB | 1 |
| Dolgorukova, A; Lyubashina, OA; Murzina, AA; Potapenko, AV; Y Sokolov, A | 1 |
| Abd-ElGawad, M; Abdelhay, HM; Abdelmonem, H; Abdelwadoud, GT; Ahmed, AE; Al-Dardery, NM; Alhosini, ANM; Kamel, MA; Mohamed, SW | 1 |
12 review(s) available for valproic acid and sumatriptan
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Therapeutic advances in migraine.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Dihydroergotamine; Female; Humans; Indoles; Male; Migraine Disorders; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sulfonamides; Sumatriptan; Valproic Acid | 1993 |
The therapeutics of migraine.
Topics: Brain; Humans; Indoles; Migraine Disorders; Neurons; Serotonin Receptor Agonists; Sulfonamides; Sumatriptan; Valproic Acid; Vasoconstriction | 1993 |
Acute and prophylactic treatment of migraine: practical approaches and pharmacologic rationale.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Dihydroergotamine; Ergotamine; Humans; Indoles; Migraine Disorders; Phenothiazines; Serotonin Receptor Agonists; Sulfonamides; Sumatriptan; Valproic Acid | 1993 |
Diagnosis, prophylaxis, and treatment of headaches in the athlete.
Topics: Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Chronic Disease; Cluster Headache; Dihydroergotamine; Female; GABA Agents; Headache; Humans; Male; Migraine Disorders; Nortriptyline; Physical Exertion; Psychomotor Performance; Recurrence; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sports; Sumatriptan; Tension-Type Headache; Valproic Acid; Vasodilator Agents; Verapamil | 1997 |
[Migraine and neurotransmitters].
Topics: GABA Agents; Indoles; Isoindoles; Migraine Disorders; Neurokinin-1 Receptor Antagonists; Neurotransmitter Agents; Serotonin Antagonists; Sumatriptan; Valproic Acid | 1998 |
Medication-induced headache: overview and systematic review of therapeutic approaches.
Topics: Amitriptyline; Analgesics; Anti-Inflammatory Agents; Chronic Disease; Ergolines; Headache; Humans; MEDLINE; Piracetam; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome; Sumatriptan; Thiazines; Valproic Acid | 1999 |
The impact of pharmacogenetics for migraine.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Calcium Channel Blockers; Calcium Channels; Chromosomes, Human, Pair 19; Ergot Alkaloids; Humans; Migraine Disorders; Mutation; Pharmacogenetics; Receptors, Dopamine D2; Sumatriptan; Valproic Acid | 2001 |
Cluster headache: review of the literature.
Topics: Anticonvulsants; Clinical Protocols; Cluster Headache; Diagnosis, Differential; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Review Literature as Topic; Serotonin Receptor Agonists; Sumatriptan; Valproic Acid | 2001 |
[Treatment of idiopathic headache in childhood - recommendations of the German Migraine and Headache Society (DMKG)].
Topics: Acetaminophen; Adrenergic beta-Antagonists; Age Factors; Analgesics, Non-Narcotic; Biofeedback, Psychology; Child; Flunarizine; GABA Agents; Headache; Humans; Ibuprofen; Metoprolol; Migraine Disorders; Practice Guidelines as Topic; Propranolol; Relaxation Therapy; Serotonin Receptor Agonists; Sumatriptan; Tension-Type Headache; Valproic Acid; Vasodilator Agents | 2002 |
Efficacy of ketorolac in the treatment of acute migraine attack: A systematic review and meta-analysis.
Topics: Caffeine; Dexamethasone; Diclofenac; Humans; Ketorolac; Metoclopramide; Migraine Disorders; Pain; Phenothiazines; Sumatriptan; Valproic Acid | 2022 |
The efficacy and safety of metoclopramide in relieving acute migraine attacks compared with other anti-migraine drugs: a systematic review and network meta-analysis of randomized controlled trials.
Topics: Chlorpromazine; Granisetron; Headache; Humans; Ketorolac; Metoclopramide; Migraine Disorders; Nausea; Network Meta-Analysis; Prochlorperazine; Randomized Controlled Trials as Topic; Sumatriptan; Valproic Acid | 2023 |
3 trial(s) available for valproic acid and sumatriptan
| Article | Year |
|---|---|
Altered neuroendocrine control of GH secretion in normal women of advanced reproductive age.
Topics: Adult; Aging; Dopamine Agonists; Female; GABA Agonists; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Levodopa; Middle Aged; Neurosecretory Systems; Reference Values; Reproduction; Serotonin Receptor Agonists; Sumatriptan; Valproic Acid | 1997 |
A randomized open-label study of sodium valproate vs sumatriptan and metoclopramide for prolonged migraine headache.
Topics: Acute Disease; Adult; Analgesics; Dopamine Antagonists; Drug Therapy, Combination; Female; GABA Agents; Humans; Injections, Intramuscular; Injections, Intravenous; Injections, Subcutaneous; Male; Metoclopramide; Migraine without Aura; Pain Measurement; Prospective Studies; Serotonin 5-HT1 Receptor Agonists; Severity of Illness Index; Sumatriptan; Treatment Outcome; Valproic Acid | 2013 |
Intravenous Valproate versus Subcutaneous Sumatriptan in Acute Migraine Attack.
Topics: Adult; Female; Humans; Male; Middle Aged; Migraine Disorders; Nausea; Recurrence; Sumatriptan; Valproic Acid; Vasoconstrictor Agents; Young Adult | 2015 |
22 other study(ies) available for valproic acid and sumatriptan
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Migraine relief.
Topics: GABA Agents; Humans; Migraine Disorders; Sumatriptan; Valproic Acid; Vasoconstrictor Agents | 1997 |
Relief for migraine sufferers.
Topics: GABA Agents; Humans; Migraine Disorders; Sumatriptan; Valproic Acid; Vasoconstrictor Agents | 1998 |
New "triptans" and other drugs for migraine.
Topics: Adrenergic beta-Antagonists; Amitriptyline; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Calcium Channel Blockers; Dihydroergotamine; Drug Interactions; Ergotamine; Humans; Indoles; Methysergide; Migraine Disorders; Naproxen; Oxazoles; Oxazolidinones; Piperidines; Propranolol; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Timolol; Triazoles; Tryptamines; Valproic Acid; Vasoconstrictor Agents | 1998 |
Cerebral blood flow effects of sodium valproate in drug combinations in the baboon model.
Topics: Acetazolamide; Animals; Anticonvulsants; Carbonic Anhydrase Inhibitors; Cerebrovascular Circulation; Drug Interactions; Hemodynamics; Male; Nimodipine; Papio; Radiopharmaceuticals; Sumatriptan; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon; Valproic Acid; Vasoconstrictor Agents; Vasodilator Agents | 1998 |
Migraine polypharmacy and the tolerability of sumatriptan: a large-scale, prospective study.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Anti-Asthmatic Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Antidepressive Agents; Cardiovascular Agents; Cohort Studies; Comorbidity; Contraceptives, Oral, Hormonal; Depression; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Epilepsy; Female; Humans; Hypnotics and Sedatives; Injections, Subcutaneous; Male; Methysergide; Middle Aged; Migraine Disorders; Patient Acceptance of Health Care; Prospective Studies; Serotonin Receptor Agonists; Smoking; Sumatriptan; Valproic Acid; Vasoconstrictor Agents | 1999 |
Hereditary haemochromatosis in two cousins with cluster headache.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Brain Stem; Calcium Channel Blockers; Cluster Headache; Drug Resistance; Female; Ferritins; Genotype; Hemochromatosis; Hemochromatosis Protein; Histocompatibility Antigens Class I; HLA Antigens; Humans; Iron; Male; Membrane Proteins; Middle Aged; Migraine with Aura; Mutation, Missense; Phlebotomy; Serotonin Receptor Agonists; Sumatriptan; Transferrin; Valproic Acid; Verapamil | 2002 |
Migraine preventive medication reduces resource utilization.
Topics: Amitriptyline; Cohort Studies; Health Resources; Humans; Migraine Disorders; Practice Guidelines as Topic; Retrospective Studies; Serotonin Receptor Agonists; Sumatriptan; United States; Valproic Acid | 2003 |
An adult case of cyclic vomiting syndrome successfully responding to valproic acid.
Topics: Anti-Anxiety Agents; Anticonvulsants; Antiemetics; Consciousness Disorders; Diazepam; Female; Humans; Middle Aged; Migraine Disorders; Recurrence; Sumatriptan; Syndrome; Valproic Acid; Vascular Headaches; Vasoconstrictor Agents; Vomiting | 2008 |
Management of cluster headache.
Topics: Analgesics; Cluster Headache; Deep Brain Stimulation; Disease Management; Ergotamine; Fructose; Humans; Hypothalamus; Lithium; Methysergide; Oxygen; Prevalence; Randomized Controlled Trials as Topic; Sumatriptan; Topiramate; Valproic Acid; Verapamil | 2012 |
[Therapeuetic aspects of cluster headache in the practical clinical site].
Topics: Adult; Amines; Amitriptyline; Cluster Headache; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Injections, Subcutaneous; Male; Middle Aged; Self Care; Sumatriptan; Valproic Acid; Young Adult | 2013 |
The effects of acute and preventive migraine therapies in a mouse model of chronic migraine.
Topics: Acute Disease; Amiloride; Animals; Anticonvulsants; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Humans; Male; Mice; Migraine Disorders; Nitroglycerin; Pain Measurement; Propranolol; Serotonin 5-HT1 Receptor Agonists; Species Specificity; Sumatriptan; Treatment Outcome; Valproic Acid; Vasodilator Agents | 2016 |
The implementation of transcranial Doppler ultrasonography for preclinical study of migraine.
Topics: Animals; Blood Flow Velocity; Cerebrovascular Circulation; Humans; Migraine Disorders; Rats; Reproducibility of Results; Sumatriptan; Ultrasonography, Doppler, Transcranial; Valproic Acid | 2022 |